This course is designed for residents, consultants, and allied health professionals in otorhinolaryngology – head and neck surgery, general and endocrine surgery, endocrinology, and oncology involved in the management of thyroid cancer. It covers the fundamental principles of epidemiology, basic sciences, diagnostics, treatment modalities, and follow-up of thyroid cancer patients. The second day, focusing on new developments and controversies in medullary thyroid cancer, is dedicated to those with a specific interest in medullary thyroid cancer. This is a multidisciplinary course, and all professionals involved in thyroid cancer care are welcome.
The event is badged and supported by:
- European Head and Neck Society (EHNS)
- British Association of Head and Neck Oncologists
- British Association of Endocrine and Thyroid Surgeons (BAETS)
- British Thyroid Association (BTA)
- Confederation of Otorhinolaryngology Head and Neck Surgery (CEORL-HNS)
- ENT UK Head and Neck Society
Who should attend?
This event is targeted at all members of thyroid multidisciplinary teams involved in the treatment of thyroid cancer, including qualified staff and trainees. This includes surgeons, endocrinologists, nuclear physicians, oncologists, clinical nurse specialists, and speech and language therapists.
- Venue: Tower Lecture Theatre and Robens Suite
- Location: 29th Floor, Guy's Hospital, Great Maze Pond, London, SE1 9RT
- Date: 18/06/2026 to 19/06/2026
4th New Developments and Controversies in Thyroid Cancer - Flyer
